small molecule glp 1 agonist How GLP-1 Receptor Agonists Evolved from Diabetes Treatments to Weight Loss Treatments Full-length human GLP-1 receptor structure
Description
Diabetologia 60 , 17311739 (2017)
, , ,
Therefore, despite its hyperglycaemic action, glucagon triggers lipid catabolism and energy expenditure and reduces food intake (Fig
Metabolism 114:154415 Budd J, Cusi K (2020) Role of agents for the treatment of diabetes in the management of nonalcoholic fatty liver disease
1,2 GLP-1RAs have been available on the PBS since 2010
Food intake, body weight, body mass content, energy intake, and total energy expenditure outcome measures were analysed as continuous variables and as end point variables and were not transformed
